Purpose: Clindamycin is commonly used in the treatment of erythromycin resistant Staphylococcus aureus causing skin and soft tissue infections. In vitro routine tests for clindamycin susceptibility may fail to detect inducible clindamycin resistance due to erm genes resulting in treatment failure, thus necessitating the need to detect such resistance by a simple D test on routine basis. Materials and Method: 234Staphylococcus aureus isolates were subjected to routine antibiotic susceptibility testing including cefoxitin (30mcg) by Kirby Bauer disc diffusion method. Inducible clindamycin resistance was detected by D test, as per CLSI guidelines on erythromycin resistant isolates. Results: 59 (42.44%) isolates showed inducible clindamycin resistance, 39 (28.05%) showed constitutive resistance while remaining 41 (29.49%) showed MS phenotype. Inducible resistance and constitutive resistance were found to be higher in MRSA as compared to MSSA (35.83%, 28.33% and 14.03%, 4.38% respectively).
Introduction
Emergence of methicillin resistance in Staphylococcus aureus has left us with very few therapeutic alternatives available to treat staphylococcal infections. The macrolide-lincosamide-streptogramin B (MLS B ) family of antibiotics serves as one such alternative, with clindamycin being the preferred agent due its excellent pharmacokinetic properties. [1] However, widespread use of MLS B antibiotics has led to an increase in number of staphylococcal strains acquiring resistance to MLS B antibiotics.
[2] The most common mechanism for such resistance is target site modification mediated by erm genes which can be expressed either constitutively (constitutive MLS B phenotype) or inducibely (inducible MLS B phenotype). Strains with inducible resistance to clindamycin are difficult to detect in the routine laboratory as they appear erythromycin resistant and clindamycin sensitive in vitro when not placed adjacent to each other. In such cases, in vivo therapy with clindamycin may select constitutive erm mutants leading to clinical therapeutic failure. In case of another mechanism of resistance mediated through msrA genes i.e. efflux of antibiotic, Staphylococcal isolates appear erythromycin resistant and clindamycin sensitive both in vivo and in vitro and the strain does not typically become clindamycin resistant during therapy. [3] This study demonstrates a very simple method of detecting inducible resistance to clindamycin in erythromycin resistant staphylococcal isolates. i.e. D test as described by Fiebelkorn et al. [1] , [4] 
Materials and Methods
The study was conducted from October 2010 to July 2011. A total of 234 isolates of Staphylococcus aureus isolated from various clinical specimens like pus, wound swab, aspirates, blood, and sterile fluids were tested. The isolates were first identified as S. auerus by standard biochemical techniques [5] and then subjected to susceptibility testing by Kirby Bauer›s disc diffusion method on Mueller Hinton agar plates using erythromycin (15mcg), penicillin (10U), ciprofloxacin (5 mcg), vancomycin (30mcg) and cefoxitin (30 mcg) as per CLSI guidelines. Methicillin resistance was detected using cefoxitin (30 mcg) on Mueller Hinton agar by incubation at 370 C. [4] Those isolates which were erythromycin resistant were further subjected to 'D test' as per CLSI guidelines. Briefly, erythromycin (15 mcg) disc was placed at a distance of 15mm (edge to edge) from clindamycin (2 mcg) disc on a Mueller Hinton agar plate previously inoculated with 0.5 McFarland bacterial suspension. Following overnight incubation at 37 0 C, flattening of zone (D shaped) around clindamycin in the area between the two discs, indicated inducible clindamycin resistance [4] [Figure ] b. Three different phenotypes were appreciated after testing and interpreted as follows: Figure : 
Results
Two hundred and thirty four Staphylococcal isolates were tested for susceptibility to erythromycin and other antibiotics of the panel by routine disc diffusion testing; 139 (59.40%) of them were erythromycin resistant. These isolates when subjected to D test showed nine39 (28.05%) isolates resistant to both erythromycin and clindamycin indicating constitutive MLS B Phenotype; 100 isolates showed clindamycin sensitivity. Out of these, 59 isolates showed positive D test indicating inducible MLS B phenotype while 41 gave negative D test indicating MS phenotype [ Table 1 ]. The overall percentage resistance for all three phenotypes was as follows.
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Discussion
The determination of antimicrobial susceptibility of a clinical isolate is often crucial for optimal antimicrobial therapy of infected patients. This is particularly important considering the increase of resistance and the emergence of multidrug resistant organisms. In the light of the restricted range of antibiotics available for the treatment of methicillin-resistant staphylococcal infections and the known limitations of vancomycin, clindamycin should be considered for the management of serious soft tissue infections with methicillin-resistant staphylococci that are sensitive to clindamycin.
[13] The true sensitivity to clindamycin can only be judged after performing D test on the erythromycin resistant isolates. The prevalence of inducible clindamycin resistance may vary from hospital to hospital. Although we did not study the prevalence of inducible clindamycin resistance in our area, from the current study, we can conclude that there is a fairly high percentage of inducible clindamycin resistance amongst the staphylococcal isolates which shows erythromycin resistance.
Use of D test in a routine laboratory will enable us in guiding the clinicians regarding judicious use of clindamycin in skin and soft tissue infections; as clindamycin is not a suitable drug for D test positive isolates while it can definitely prove to be a drug of choice in case of D test negative isolates.
